Medistim ASA (FRA:MD1)

Market Cap	525.31M +38.8%
Revenue (ttm)	73.09M +19.1%
Net Income	16.38M +25.3%
EPS	n/a
Shares Out	n/a
PE Ratio	32.07
Forward PE	28.22
Dividend	0.97 (3.41%)
Ex-Dividend Date	Oct 23, 2026

Volume	5
Open	26.70
Previous Close	27.10
Day's Range	26.70 - 28.50
52-Week Range	16.30 - 28.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 159
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MD1

Financial Performance

In 2025, Medistim ASA's revenue was 699.77 million, an increase of 24.38% compared to the previous year's 562.60 million. Earnings were 159.21 million, an increase of 53.33%.

Financial numbers in NOK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error